ATE74919T1 - 1,2-disubstituierte ergolinderivate. - Google Patents
1,2-disubstituierte ergolinderivate.Info
- Publication number
- ATE74919T1 ATE74919T1 AT86730153T AT86730153T ATE74919T1 AT E74919 T1 ATE74919 T1 AT E74919T1 AT 86730153 T AT86730153 T AT 86730153T AT 86730153 T AT86730153 T AT 86730153T AT E74919 T1 ATE74919 T1 AT E74919T1
- Authority
- AT
- Austria
- Prior art keywords
- lower alkyl
- optionally
- substituted
- group
- alkyl group
- Prior art date
Links
- AWFDCTXCTHGORH-HGHGUNKESA-N 6-[4-[(6ar,9r,10ar)-5-bromo-7-methyl-6,6a,8,9,10,10a-hexahydro-4h-indolo[4,3-fg]quinoline-9-carbonyl]piperazin-1-yl]-1-methylpyridin-2-one Chemical class O=C([C@H]1CN([C@H]2[C@@H](C=3C=CC=C4NC(Br)=C(C=34)C2)C1)C)N(CC1)CCN1C1=CC=CC(=O)N1C AWFDCTXCTHGORH-HGHGUNKESA-N 0.000 title abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 5
- 125000002252 acyl group Chemical group 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 125000003107 substituted aryl group Chemical group 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229920006395 saturated elastomer Polymers 0.000 abstract 1
- 229910052717 sulfur Chemical group 0.000 abstract 1
- 125000004434 sulfur atom Chemical group 0.000 abstract 1
- 125000001412 tetrahydropyranyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
- C07D457/10—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hetero atoms directly attached in position 8
- C07D457/12—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19853535929 DE3535929A1 (de) | 1985-10-04 | 1985-10-04 | 1,2-disubstituierte ergolinderivate |
| EP86730153A EP0217736B1 (de) | 1985-10-04 | 1986-10-03 | 1,2-Disubstituierte Ergolinderivate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE74919T1 true ATE74919T1 (de) | 1992-05-15 |
Family
ID=6283084
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT86730153T ATE74919T1 (de) | 1985-10-04 | 1986-10-03 | 1,2-disubstituierte ergolinderivate. |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US4874768A (enExample) |
| EP (1) | EP0217736B1 (enExample) |
| JP (1) | JPH0670051B2 (enExample) |
| AT (1) | ATE74919T1 (enExample) |
| CS (1) | CS259893B2 (enExample) |
| DE (2) | DE3535929A1 (enExample) |
| ES (1) | ES2051694T3 (enExample) |
| GR (1) | GR3005135T3 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3620293A1 (de) * | 1986-06-16 | 1987-12-17 | Schering Ag | 1-und/oder 2-substituierte ergolinderivate |
| DE3824659A1 (de) * | 1988-07-15 | 1990-02-08 | Schering Ag | 2-, 12- oder 13-substituierte 3-(8'(alpha)-ergolinyl)-1,1-diethylharnstoffe, ihre herstellung und verwendung in arzneimitteln |
| DK338789A (da) * | 1988-07-15 | 1990-01-16 | Schering Ag | 2-substituerede ergolinylurinstofderivater og fremgangsmaade til fremstilling deraf, deres anvendelse som laegemidler samt mellemprodukter til fremstilling deraf |
| TW252979B (enExample) * | 1992-12-24 | 1995-08-01 | Erba Carlo Spa | |
| DE10041478A1 (de) | 2000-08-24 | 2002-03-14 | Sanol Arznei Schwarz Gmbh | Neue pharmazeutische Zusammensetzung |
| DE10334188B4 (de) * | 2003-07-26 | 2007-07-05 | Schwarz Pharma Ag | Verwendung von Rotigotin zur Behandlung von Depressionen |
| DE10334187A1 (de) * | 2003-07-26 | 2005-03-03 | Schwarz Pharma Ag | Substituierte 2-Aminotetraline zur Behandlung von Depressionen |
| EP2083008A1 (en) * | 2007-12-07 | 2009-07-29 | Axxonis Pharma AG | Ergoline derivatives as selective radical scavengers for neurons |
| BR112017015487A2 (pt) | 2015-01-20 | 2018-01-30 | Xoc Pharmaceuticals Inc | Composto; composição; método de tratamento e/ou prevenção de enxaqueca, als, doença de alzheimer, doença de parkinson, distúrbios extrapirimidais, depressão, náusea, êmese, síndrome das pernas inquietas, insônia, agressão, doença de huntington, doença cardiopulmonar, fibrogênese, hipertensão arterial pulmonar, ansiedade, dependências a drogas, distonia, parassonia ou hiperlactinemia em um indivíduo; métodos de agonização dos receptores d2, 5-ht1d, 5-ht1a e 5-ht2c, em um indivíduo; método de antagonização do receptor d3 em um indivíduo; métodos de agonização seletiva dos receptores 5 -ht1d, e 5-ht2c, método de fornecimento de atividade de antagonista funcional no receptor 5 -ht2b ou no receptor 5-ht7, ou em ambos, em um indivíduo; método de fornecimento de atividade de antagonista funcional nos receptores adrenérgicos em um indivíduo |
| CA3064274A1 (en) | 2017-06-01 | 2018-12-06 | Xoc Pharmaceuticals, Inc. | Ergoline derivatives for use in medicine |
| EP4423084A4 (en) * | 2021-10-26 | 2025-12-10 | Diamond Therapeutics Inc | 5-HT2A RECEPTOR ERGOLINE-DERIVED AGONISTS |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2656344A1 (de) * | 1975-12-23 | 1977-07-07 | Sandoz Ag | Ergolinderivate, ihre verwendung und herstellung |
| CH622518A5 (en) * | 1976-12-14 | 1981-04-15 | Sandoz Ag | Process for the preparation of novel ergoline compounds |
| DE3101535A1 (de) * | 1981-01-14 | 1982-08-12 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | Neue (2-halogen-ergolinyl)-n'.n'-diethyl-harnstoffderivate, verfahren zu ihrer herstellung und deren verwendung als arzneimittel |
| DE3151912A1 (de) * | 1981-12-23 | 1983-06-30 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | Neue ergolin-aminoderivate, verfahren zu ihrer herstellung und deren verwendung als arzneimittel |
| DE3309493A1 (de) * | 1983-03-14 | 1984-09-20 | Schering AG, 1000 Berlin und 4709 Bergkamen | Neue ergolin-derivate, verfahren zu ihrer herstellung sowie verwendung als arzneimittel |
| PH21123A (en) * | 1983-04-28 | 1987-07-27 | Erba Farmitalia | Ergoline derivatives |
| DE3413659A1 (de) * | 1984-04-09 | 1985-10-17 | Schering AG, 1000 Berlin und 4709 Bergkamen | Neue 2-substituierte ergolin-derivate |
| EP0160842B1 (de) * | 1984-04-09 | 1994-06-22 | Schering Aktiengesellschaft | 2-substituierte Ergolin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| DE3533675A1 (de) * | 1985-09-19 | 1987-03-26 | Schering Ag | Neue 12- und 13-brom-ergolinderivate |
-
1985
- 1985-10-04 DE DE19853535929 patent/DE3535929A1/de not_active Withdrawn
-
1986
- 1986-10-03 ES ES86730153T patent/ES2051694T3/es not_active Expired - Lifetime
- 1986-10-03 CS CS867154A patent/CS259893B2/cs unknown
- 1986-10-03 DE DE8686730153T patent/DE3684855D1/de not_active Expired - Lifetime
- 1986-10-03 AT AT86730153T patent/ATE74919T1/de not_active IP Right Cessation
- 1986-10-03 EP EP86730153A patent/EP0217736B1/de not_active Expired - Lifetime
- 1986-10-03 JP JP61234693A patent/JPH0670051B2/ja not_active Expired - Lifetime
- 1986-10-06 US US06/915,358 patent/US4874768A/en not_active Expired - Fee Related
-
1992
- 1992-07-10 GR GR920401190T patent/GR3005135T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JPS62174075A (ja) | 1987-07-30 |
| DE3535929A1 (de) | 1987-04-09 |
| DE3684855D1 (de) | 1992-05-21 |
| CS259893B2 (en) | 1988-11-15 |
| EP0217736A3 (en) | 1989-03-22 |
| JPH0670051B2 (ja) | 1994-09-07 |
| US4874768A (en) | 1989-10-17 |
| ES2051694T3 (es) | 1994-07-01 |
| CS715486A2 (en) | 1988-03-15 |
| EP0217736A2 (de) | 1987-04-08 |
| GR3005135T3 (enExample) | 1993-05-24 |
| EP0217736B1 (de) | 1992-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE12094T1 (de) | Neue carbacycline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel. | |
| ATE74919T1 (de) | 1,2-disubstituierte ergolinderivate. | |
| SE7605361L (sv) | Sett att framstella nya n-substituerade fenylpiperazinderivat | |
| ATE27817T1 (de) | Phenylpiperazin-derivate und verfahren zu deren herstellung. | |
| DK152750C (da) | Analogifremgangsmaade til fremstilling af carbacyklinderivater | |
| ATE3111T1 (de) | Verfahren zur herstellung von phenyl-propylmorpholin- und -piperidin-derivaten. | |
| DK373783D0 (da) | Thieno-thiazol-derivater, fremgangsmade til deres fremstilling samt deres anvendelse | |
| ES536649A0 (es) | Procedimiento para la preparacion de derivados de estrano y androstano | |
| KR850000455A (ko) | 세팔로스포린 에스테르 유도체의 제조방법 | |
| ES463783A1 (es) | Un procedimiento para la preparacion de cis-4a-aril-octahi- dro-1h-2-pirindinas 2-sustituidas. | |
| ES472429A1 (es) | Un procedimiento para la preparacion de compuestos de 4-de-soxi-4-amino-eritromicina a. | |
| KR830007580A (ko) | 신규 피리미딘 유도체의 제조방법 | |
| ES520486A0 (es) | Procedimiento para la preparacion de fenoleteres biciclicos. | |
| SE8703494L (sv) | Mellanprodukter anvendbara vid framstellning av 2-tiofen-ettiksyraderivat | |
| ATE52770T1 (de) | Neue carbacycline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel. | |
| GB2001062A (en) | Preparation of Pyridinecarboxylic acid piperazides | |
| GB2002350A (en) | Preparation of tetramisole intermediate | |
| ATE86629T1 (de) | 4-piperidincarboxamid-derivate. | |
| NO874627D0 (no) | Fremgangsmaate for fremstilling av 4-hydroxy-4-(substituerte alkenyl)cyklohexancarboxylsyrer. | |
| GB1056936A (en) | Novel pregnane compounds and processes for their preparation | |
| GB905823A (en) | Alkaloid derivatives and process for preparation | |
| ES8304918A1 (es) | "procedimiento para la preparacion de cetoaminas". | |
| SE8102877L (sv) | Nya 16-amino-prostaglandinderivat jemte sett for deras framstellning |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REN | Ceased due to non-payment of the annual fee |